- Home
- ATHA vs WAI Comparison
ATHA vs WAI Comparison
Compare ATHA & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- WAI
- Stock Information
- Founded
- ATHA 2011
- WAI 2018
- Country
- ATHA United States
- WAI China
- Employees
- ATHA N/A
- WAI N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- WAI
- Sector
- ATHA Health Care
- WAI
- Exchange
- ATHA Nasdaq
- WAI NYSE
- Market Cap
- ATHA 93.5M
- WAI 87.8M
- IPO Year
- ATHA 2020
- WAI 2023
- Fundamental
- Price
- ATHA $0.67
- WAI $0.48
- Analyst Decision
- ATHA Buy
- WAI
- Analyst Count
- ATHA 4
- WAI 0
- Target Price
- ATHA $11.25
- WAI N/A
- AVG Volume (30 Days)
- ATHA 14.2M
- WAI 67.4K
- Earning Date
- ATHA 11-07-2024
- WAI 11-22-2024
- Dividend Yield
- ATHA N/A
- WAI N/A
- EPS Growth
- ATHA N/A
- WAI N/A
- EPS
- ATHA N/A
- WAI N/A
- Revenue
- ATHA N/A
- WAI $3,989,698.00
- Revenue This Year
- ATHA N/A
- WAI N/A
- Revenue Next Year
- ATHA N/A
- WAI N/A
- P/E Ratio
- ATHA N/A
- WAI N/A
- Revenue Growth
- ATHA N/A
- WAI N/A
- 52 Week Low
- ATHA $0.41
- WAI $0.19
- 52 Week High
- ATHA $4.30
- WAI $2.14
- Technical
- Relative Strength Index (RSI)
- ATHA 51.78
- WAI N/A
- Support Level
- ATHA $0.60
- WAI N/A
- Resistance Level
- ATHA $0.83
- WAI N/A
- Average True Range (ATR)
- ATHA 0.10
- WAI 0.00
- MACD
- ATHA 0.03
- WAI 0.00
- Stochastic Oscillator
- ATHA 61.60
- WAI 0.00
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides a number of essential business services in China to young and emerging companies including corporate business training services, which mainly focus on advanced knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising, and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).